Buscar resultados de ensayos clínicos
Respiratory Syncytial Virus Infections - 28 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Safety Study of Oral BTA9881 to Treat RSV Infection Condición: Respiratory Syncytial Virus Infections Fecha: 2007-07-18 Intervenciones:
|
Terminated |
Nombre del estudio: Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients Condición: Respiratory Syncytial Virus Infections Fecha: 2002-03-06 Intervenciones: Drug: Virazole (Ribavirin) Inhalation Solution |
Completed |
Nombre del estudio: Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children Condición: Respiratory Syncytial Virus Infection Fecha: 2008-01-03 |
Completed |
Nombre del estudio: A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT Condición: Respiratory Syncytial Virus Infections Fecha: 2005-10-04 Intervenciones: Drug: A-60444 |
Active, not recruiting |
Nombre del estudio: Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants Condición: Respiratory Syncytial Virus Infections Fecha: 2014-12-21 Intervenciones:
|
Completed |
Nombre del estudio: Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial) Condición:
|
Completed |
Nombre del estudio: Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions Condición: Respiratory Syncytial Virus Infection Fecha: 2011-09-12 Intervenciones: Drug: Palivizumab Other Names:
|
Completed |
Nombre del estudio: ALX-0171 Safety Study in Adults With Hyperresponsive Airways Condición: Respiratory Syncytial Virus Infection Fecha: 2013-07-24 Intervenciones: Biological: ALX-0171 Escalating dose of ALX-0171 during maximum 3 consecutive days: from 2.1 mg to maxim |
Completed |
Nombre del estudio: Surveillance of Synagis in Korean Pediatric Patients Condición: Respiratory Syncytial Virus Infection Fecha: 2011-12-15 |
Recruiting |
Nombre del estudio: Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age Condición: Respiratory Syncytial Virus Infections Fecha: 2017-03-23 Intervenciones:
|